ERA Testing Package (Enhance Fertility Planning)

· Those in Bangkok looking for advanced fertility diagnostics before embryo transfer.
· Those with multiple failed IVF attempts want to optimize embryo implantation timing.
· Those with unexplained infertility.
· Those who want to maximise chances of successful implantation.
· Those who wish to increase chances of pregnancy after previous IVF success that failed in subsequent attempts.

ERA Testing Package is a diagnostic tool designed to evaluate endometrial receptivity and determine the optimal timing for embryo transfer during a fertility treatment cycle. The test examines the uterine lining at the molecular level, analysing the activity of approximately 248 genes associated with implantation readiness. By identifying whether the endometrium is receptive, pre-receptive, or post-receptive, doctors can plan the embryo transfer at the most suitable window, potentially improving chances of successful implantation.

ERA Testing Package provides benefits beyond timing identification. It helps in cases of recurrent implantation failure by showing delays or advances in endometrial development that may reduce implantation success. It also guides adjustments in hormone administration, ensuring synchronization between embryo development and uterine readiness. For patients preparing for frozen embryo transfer or donor-egg procedures, the test offers additional confidence in the timing strategy recommended by the doctor.

ERA Testing Package serves as an informative step in fertility planning by offering data-driven insights that complement other IVF procedures. By providing a personalised transfer schedule, the package may reduce the number of failed attempts, lower emotional and financial stress, and increase efficiency of treatment cycles. Integration of ERA results into fertility planning allows doctors to make precise, evidence-based recommendations that enhance the likelihood of pregnancy success while minimising unnecessary interventions.

ERA Testing Package begins with consultation by the doctor at our affiliated hospital to review medical history, previous IVF cycles, and any implantation challenges. During this initial visit, the doctor explains the testing process, expected outcomes, and potential benefits. The consultation typically takes around 30 to 45 minutes.

Following consultation, the patient will undergo a preparatory hormone cycle, administered and monitored by the doctor at our affiliated hospital. Estrogen and progesterone are given to simulate conditions of a real embryo transfer cycle, ensuring the endometrium develops similarly to a transfer cycle. This preparation usually lasts 12 to 16 days, depending on the patient’s natural cycle and hormone response.

On the scheduled day for the biopsy, which takes approximately 10 to 15 minutes, a small sample of the endometrial lining is collected using a thin catheter. The procedure is minimally invasive and performed under local anaesthesia if needed. Most patients experience only mild cramping or light spotting for 1 to 2 days. There is generally no significant downtime, allowing normal daily activities to resume shortly after the procedure.

The collected tissue is sent to a specialized laboratory for molecular analysis of gene expression related to endometrial receptivity. Within about 7 to 10 days, results are available and indicate whether the lining was receptive, pre-receptive, or post-receptive at the time of biopsy. The doctor then reviews the report and recommends a personalized embryo transfer schedule based on the optimal window of implantation. The procedure’s minimally invasive and virtually no recovery period, making it a convenient and informative step in assisted reproductive treatment.

1. Consultation will be conducted by the doctor.
2. Endometrial biopsy will be performed.
3. Tissue analysis will be conducted.
4. Follow-up consultation will be scheduled by the doctor for result analysis and plan personalised embryo transfer.

<Advantages>
· Optimises embryo transfer timing
· Reduces repeated IVF cycles
· Minimises uncertainty in fertility planning
· Improves efficiency of fertility treatment cycles
· Strengthens preparation for frozen embryo transfer (FET) cycles

<Limitations>
· Temporary mild cramping and light spotting may occur for 1 to 2 days after procedure

· Avoid vaginal medications, douching, or sexual intercourse for 24 hours before procedure
· Maintain healthy diet and stay hydrated 1 week before procedure

· Avoid strenuous exercise for at least 1 day after procedure
· Maintain healthy diet and stay hydrated after procedure
· Monitor for signs of infection (fever, heavy bleeding, or unusual discharge) for 1 week and contact the doctor if any appear

Q1: How does ERA Testing Package improve implantation?
A1: ERA Testing Package analyses gene expression in endometrial tissue, helping the doctor at our affiliated hospital plan embryo transfer at the most receptive window.

Q2: Is there any downtime after ERA Testing Package?
A2: ERA Testing Package has minimal downtime. Normal activities can usually resume immediately, with only mild cramping or spotting for 1 to 2 days.

Q3: When will ERA Testing Package results be available?
A3: Results from ERA Testing Package are typically available within 7 to 10 days.

Q4: Is ERA Testing Package suitable for women with irregular cycles?
A4: Yes, ERA Testing Package is suitable for women with irregular cycles, as hormone preparation standardises timing for accurate assessment.

Q5: Can ERA Testing Package reduce failed IVF cycles?
A5: Yes, ERA Testing Package helps reduce failed IVF cycles by providing precise timing for embryo transfer.

[Clinic Name] Thonburi Bamrungmuang Hospital
[Location] Bangkok, Thailand
[Nearest Station/ Nearest Tourist Destination] A 10 mins drive from Hua Lamphong MRT station; 5 mins drive from National Stadium BTS station
[Clinic Opening Time] 24 hrs

Trambellir is a health tourism platform and does not in any way provide, promote, or sell any medication or medical treatment to the Customers.
Customers are advised to contact the healthcare providers directly for any enquiries related to medical treatments.